Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma.
Journal: British journal of haematology
Published: June 23, 2017
A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers.
Journal: Cancer investigation
Published: April 30, 2016
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma.
Journal: British journal of haematology
Published: October 18, 2013
Showing 1-3 of 3
Last Updated: 09/26/2026